|ITEM METADATA RECORD
|Title: ||Everolimus plus Octreotide LAR versus Placebo plus Octreotide LAR in Patients with Advanced NET: Results of a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Trial (RADIANT-2)|
|Authors: ||Pavel, M|
Van Cutsem, Eric
Yao, J #
|Issue Date: ||2011 |
|Publisher: ||S. Karger|
|Host Document: ||Neuroendocrinology vol:94 pages:38-39|
|Conference: ||8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease location:Lisbon, PORTUGAL date:MAR 09-11, 2011|
|Publication status: ||published|
|KU Leuven publication type: ||IMa|
|Appears in Collections:||Clinical Digestive Oncology (+)|
|Files in This Item:
There are no files associated with this item.
All items in Lirias are protected by copyright, with all rights reserved.
© Web of science